Tim Cook has been appointed to the board of Oxford Gene Technology as a non-executive director, OGT said this week.
Cook most recently served as executive director at Isis Innovation, the technology transfer company of Oxford University. Prior to Isis, he served as private investor and founding managing director of Oxford Semiconductor and Oxford Asymmetry.
Cook holds a BS in physics and a PhD in cryogenics from Oxford University.
Gene Logic will pay recently appointed CEO and president Charles Dimmler $425,000 in salary plus an incentive package worth as much as 40 percent of his salary.
The company also gave Dimmler an option to buy up to 120,000 shares of the company’s common stock at $1.37 per share that will vest in four increments spread out over three years, as well as a total of 130,000 shares as bonuses if the company achieves milestones.
Joanne Smith-Farrell has resigned from Gene Logic as senior vice president of business development and licensing, according to a filing with the Securities and Exchange Commission. Farrell will leave her post on July 31.
Sigma-Aldrich has promoted Gerrit van den Dool to the job of vice president of sales, and has named David Smoller to be president of the company’s Research Biotech business unit. Van den Dool has been with Sigma-Aldrich since 1999 and Smoller started as Sigma’s vice president of research and development in 2004.
Sequenom has appointed Richard Lerner to its board of directors. Lerner is president of the Scripps Research Institute, a professor of immunochemistry, and is a member of the Skaggs Institute for Chemical Biology at Scripps. Lerner also serves on the boards at Kraft and Opko.